Segmentation by types distinguishes three primary architectures: blade‑based, needle‑tip, and hybrid devices. Blade‑based scalpel systems dominate with an estimated 60 % market share, owing to their familiarity, low unit cost, and compatibility with a wide range of blade geometries (e.g., stainless‑steel, carbide). Needle‑tip models, comprising about 25 % of sales, target minimally invasive and microsurgical procedures where a fine, retractable tip reduces tissue trauma and enhances precision. Hybrid scalpel configurations—integrating a blade with a retractable needle mechanism—capture the remaining 15 % and are gaining traction in specialty fields that require both cutting and suturing capabilities within a single disposable unit. Each type’s contribution reflects a balance between procedural complexity, cost sensitivity, and regulatory drivers, enabling stakeholders to assess product‑mix profitability and identify growth corridors within the broader Disposable Safety Scalpel market.